STOCK TITAN

PLSAD Financials

PLSAD
FY2024 annual
Revenue $2.0B -14.1% YoY
Net Income -$2.0B -73.4% YoY
Free Cash Flow -$1.1B +43.9% YoY
Operating Cash Flow -$991.2M +47.7% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD FYE December

Newest figures come from the 10-K for Q2 FY2025, filed Sep 3, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PLSAD SEC filings page.

PLSAD (PLSAD) reported $2.0B in revenue for fiscal year 2024, down 14.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PLSAD FY2024

External financing is carrying a cash-hungry operation as losses deepen, equity erodes, and short-term liquidity tightens.

Cash conversion remains negative, but the relationship between earnings and cash changed: FY2024’s net loss was -$2.05B while operating cash flow was -$991M, indicating that a substantial portion of the accounting loss did not become same-period operating cash. Meanwhile, financing provided $1.42B against operating and investing cash outflows, making outside funding the apparent balancing mechanism.

The balance sheet moved from modest positive equity in FY2022 to -$3.33B in FY2024, while total liabilities reached $7.38B against $4.05B of assets; this is a structural solvency problem rather than merely a weak-margin year. The current ratio fell to 0.5x, meaning current assets remained below near-term obligations.

Working capital is absorbing resources: inventory rose to $1.08B in FY2024 even as revenue declined to $2.03B from $2.37B in FY2023. Free cash flow remained deeply negative at -$1.14B, so reported improvement in operating cash flow did not translate into low reinvestment needs or self-funding operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

PLSAD does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/7

PLSAD passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

PLSAD reported a net loss of $2.0B while operations used $991.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q2 2025.

Cash & Balance Sheet

Cash & Debt
$718.6M
YoY+7.4%
QoQ-2.8%

PLSAD held $718.6M in cash against $4.1B in long-term debt as of Q2 2025.

Free Cash Flow

Not reported for Q2 2025.

Dividends Per Share

Not reported for Q2 2025.

Shares Outstanding

Not reported for Q2 2025.

Margins & Returns

None of these metrics is reported for Q2 2025.

Capital Allocation

None of these metrics is reported for Q2 2025.

PLSAD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLSAD quarterly income statement
MetricQ2'2510-KQ4'2410-KQ2'2410-KQ4'2310-KQ2'23Q4'22Q2'22Q4'21
RevenueN/AN/AN/AN/A$685.2M+16.3%N/A$589.1MN/A
Interest ExpenseN/AN/AN/AN/A$1.1M+4.4%N/A$1.1MN/A
Income TaxN/AN/AN/AN/A$2.6M-4.9%N/A$2.7MN/A
Net IncomeN/AN/AN/AN/A-$304.1M-33.2%N/A-$228.2MN/A
Diluted Shares (Avg)N/AN/AN/AN/A2.11B+8.2%N/A1.95BN/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted).

PLSAD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLSAD quarterly balance sheet
MetricQ2'2510-KQ4'2410-KQ2'2410-KQ4'2310-KQ2'23Q4'22Q2'22Q4'21
Total Assets$3.6B-9.0%$4.1B-5.5%$4.0B-5.9%$4.3B+7.0%$4.3B$4.0B+21.2%N/A$3.3B
Current Assets$2.2B+20.0%$2.3B+1.1%$1.8B-23.3%$2.3B+5.9%$2.4B$2.1B+33.6%N/A$1.6B
Cash & Equivalents$718.6M+7.4%$739.2M-3.8%$668.9M-36.7%$768.3M-21.1%$1.1B-23.5%$973.9M+28.7%$1.4B$756.7M
Inventory$805.7M+12.8%$1.1B+16.3%$714.0M-17.7%$927.7M+47.2%$867.5M$630.2M+15.5%N/A$545.7M
Goodwill$837.7M-42.9%$1.0B-26.6%$1.5B0.0%$1.4B+1.8%$1.5B$1.4B+1.8%N/A$1.4B
Total Liabilities$7.9B+36.0%$7.4B+33.2%$5.8B+23.1%$5.5B+35.2%$4.7B$4.1B+28.6%N/A$3.2B
Current Liabilities$5.2B+62.1%$4.7B+30.9%$3.2B-21.2%$3.6B+13.7%$4.1B$3.2B+4.8%N/A$3.0B
Non-Current Liabilities$2.7B+3.8%$2.6B+37.6%$2.6B+298.9%$1.9B+110.4%$653.8M$912.9M+523.3%N/A$146.5M
Long-Term Debt$4.1B+9289.6%$47.9M-12.0%$43.2M-42.9%$54.4M+73.8%$75.8M$31.3M-52.9%N/A$66.6M
Total Equity-$4.3B-135.4%-$3.3B-166.1%-$1.8B-297.1%-$1.3B-1491.1%-$456.3M-168.4%$89.9M+149.0%-$170.0M-$183.5M
Retained Earnings-$8.1B-$6.9BN/AN/A-$4.0B-$3.7B-111.5%N/A-$1.8B

Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.

PLSAD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLSAD quarterly cash flow statement
MetricQ2'2510-KQ4'2410-KQ2'2410-KQ4'2310-KQ2'23Q4'22Q2'22Q4'21

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

PLSAD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PLSAD quarterly financial ratios
MetricQ2'2510-KQ4'2410-KQ2'2410-KQ4'2310-KQ2'23Q4'22Q2'22Q4'21
Net MarginN/AN/AN/AN/A-44.4%-5.6ppN/A-38.8%N/A
Return on AssetsN/AN/AN/AN/A-7.1%N/AN/AN/A
Current Ratio0.43-0.1x0.48-0.1x0.580.0x0.630.0x0.590.67+0.1xN/A0.53
Debt-to-EquityN/AN/AN/AN/AN/A0.35N/AN/A
Asset TurnoverN/AN/AN/AN/A0.16N/AN/AN/A

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Return on Equity, FCF Margin.

Note: Shareholder equity is negative (-$3.3B), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.48), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is PLSAD's annual revenue?

PLSAD (PLSAD) reported $2.0B in total revenue for fiscal year 2024. This represents a -14.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PLSAD's revenue growing?

PLSAD (PLSAD) revenue declined by 14.1% year-over-year, from $2.4B to $2.0B in fiscal year 2024.

Is PLSAD profitable?

No, PLSAD (PLSAD) reported a net income of -$2.0B in fiscal year 2024.

As of fiscal year 2024, PLSAD (PLSAD) had $739.2M in cash and equivalents against $47.9M in long-term debt.

PLSAD (PLSAD) recorded an outflow of $1.1B in free cash flow during fiscal year 2024. This represents a 43.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

PLSAD (PLSAD) recorded an outflow of $991.2M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

PLSAD (PLSAD) had $4.1B in total assets as of fiscal year 2024, including both current and long-term assets.

PLSAD (PLSAD) invested $147.9M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

PLSAD (PLSAD) had a current ratio of 0.48 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

PLSAD (PLSAD) had a return on assets of -50.6% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

PLSAD (PLSAD) has negative shareholder equity of -$3.3B as of fiscal year 2024, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

PLSAD (PLSAD) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

PLSAD (PLSAD) reported a net loss of $2.0B while operations used $991.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top